Antibacterial effect and proteomic analysis of graphene-based silver nanoparticles on a pathogenic bacterium Pseudomonas aeruginosa

BioMetals

Volumn 27, Issue 4, 2014, Pages 673-682

  He, Tingting ^a   Liu, Haitao ^a   Zhou, Yazhou ^a   Yang, Juan ^a   Cheng, Xiaonong ^a   Shi, Haifeng ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

2 DE; Proteomics; Pseudomonas aeruginosa; Silver nanoparticles

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; GRAPHITE; METAL NANOPARTICLE; PROTEOME; SILVER; SILVER NITRATE;

CHEMISTRY; DRUG EFFECTS; GENE ONTOLOGY; METABOLISM; MICROBIAL VIABILITY; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; GENE ONTOLOGY; GRAPHITE; METAL NANOPARTICLES; MICROBIAL VIABILITY; PROTEOME; PSEUDOMONAS AERUGINOSA; SILVER; SILVER NITRATE;

EID: 84905084236     PISSN: 09660844     EISSN: 15728773     Source Type: Journal    
DOI: 10.1007/s10534-014-9756-1     Document Type: Article

References (41)

1. Benn TM, Westerhoff P (2008) Nanoparticle silver released into water from commercially available sock fabrics. Environ Sci Technol 42(11):4133-4139 (Pubitemid 351770073)
2. Berti L et al (2005) DNA-templated photoinduced silver deposition. J Am Chem Soc 127(32):11216-11217 (Pubitemid 41176862)
3. Bradford A et al (2009) Impact of silver nanoparticle contamination on the genetic diversity of natural bacterial assemblages in estuarine sediments. Environ Sci Technol 43(12):4530-4536
4. Chopra I et al (2008a) Treatment of health-care-associated infections caused by gram-negative bacteria: a consensus statement. Lancet Infect Dis 8(2):133-139
5. Chopra I et al (2008b) Treatment of health-care-associated infections caused by gram-negative bacteria: a consensus statement. Lancet Infect Dis 8(2):133-139
6. Galdiero S et al (2007) beta-Barrel membrane bacterial proteins: structure, function, assembly and interaction with lipids. Curr Protein Pept Sci 8(1):63-82 (Pubitemid 46322270)
7. Gill SR et al (2005) Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J Bacteriol 187(7):2426-2438 (Pubitemid 40389140)
8. Giske CG et al (2008) Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother 52(3):813-821 (Pubitemid 351358357)
9. Handa N et al (2005) Crystal structure of a novel polyisoprenoid-binding protein from Thermus thermophilus HB8. Protein Sci 14(4):1004-1010 (Pubitemid 40389370)
10. Hayashi K et al (2006) Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 and W3110. Mol Syst Biol 2(2006):0007
11. He t et al (2013) Characterization of antibacterial effects of novel silver nanoparticles: a case study on Pseudomonas as a model for gram-negative bacteria. Adv Mater Res 621(2013):83-86
12. Hollenstein K et al (2007) Structure and mechanism of ABC transporter proteins. Curr Opin Struct Biol 17(4):412-418 (Pubitemid 47451766)
13. Irazusta V et al (2012) Proteomic study of the yeast Rhodotorula mucilaginosa RCL-11 under copper stress. Biometals 25(3):517-527
14. Jain P, Pradeep T (2005) Potential of silver nanoparticle-coated polyurethane foam as an antibacterial water filter. Biotechnol Bioeng 90(1):59-63 (Pubitemid 40547039)
15. Jena P et al (2012) Toxicity and antibacterial assessment of chitosan-coated silver nanoparticles on human pathogens and macrophage cells. Int J Nanomed 7:1805-1818
16. Klasen HJ (2000) A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns 26(2):131-138
17. Ko KM et al (2007) PYP-1, inorganic pyrophosphatase, is required for larval development and intestinal function in C. elegans. FEBS Lett 581(28):5445-5453 (Pubitemid 350101527)
18. Kurisu G et al (2001) Structure of the electron transfer complex between ferredoxin and ferredoxin-NADP(+) reductase. Nat Struct Biol 8(2):117-121 (Pubitemid 32116062)
19. Lee D et al (2005) Antibacterial properties of Ag nanoparticle loaded multilayers and formation of magnetically directed antibacterial microparticles. Langmuir 21(21):9651-9659 (Pubitemid 41507020)
20. Lee S et al (2009) Eco-toxicity of commercial silver nanopowders to bacterial and yeast strains. Biotechnol Bioprocess Eng 14(4):490-495
21. Li P et al (2005) Synergistic antibacterial effects of beta-lactam antibiotic combined with silver nanoparticles. Nanotechnology 16(9):1912-1917 (Pubitemid 41107865)
22. Li WR et al (2011) Antibacterial effect of silver nanoparticles on Staphylococcus aureus. Biometals 24(1):135-141
23. Liang HW et al (2011) Highly active carbonaceous nanofibers: a versatile scaffold for constructing multifunctional freestanding membranes. ACS Nano 5(10):8148-8161
24. Lok CN et al (2006) Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J Proteome Res 5(4):916-924
25. Lok CN et al (2007) Silver nanoparticles: partial oxidation and antibacterial activities. J Biol Inorg Chem 12(4):527-534
26. Lundqvist M et al (2008) Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA 105(38):14265-14270
27. Morones JR et al (2005) The bactericidal effect of silver nanoparticles. Nanotechnology 16(10):2346-2353 (Pubitemid 41376178)
28. Murphy CJ et al (2005) Anisotropic metal nanoparticles: synthesis, assembly, and optical applications. J Phys Chemi B 109(29):13857-13870 (Pubitemid 41163090)
29. Navarro E et al (2008) Toxicity of silver nanoparticles to Chlamydomonas reinhardtii. Environ Sci Technol 42(23):8959-8964
30. Neal AL (2008) What can be inferred from bacterium-nanoparticle interactions about the potential consequences of environmental exposure to nanoparticles? Ecotoxicology 17(5):362-371
31. Otani M et al (2001) Heat-shock-induced proteins from Myxococcus xanthus. J Bacteriol 183(21):6282-6287 (Pubitemid 34059400)
32. Page MGP, Heim J (2009) Prospects for the next anti-Pseudomonas drug. Curr Opin Pharmacol 9(5):558-565
33. Percival SL et al (2005) Bacterial resistance to silver in wound care. J Hosp Infect 60(1):1-7 (Pubitemid 40485843)
34. Rai M et al (2009) Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 27(1):76-83
35. Schulz GE (2000) beta-Barrel membrane proteins. Curr Opin Struct Biol 10(4):443-447
36. Shrivastava S et al (2007) Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology 18(22):225103. http://iopscience.iop.org/0957-4484/18/22/225103
37. Silver S (2003) Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. FEMS Microbiol Rev 27(2-3):341-353
38. Smith A et al (2012) Exposure of Staphylococcus aureus to silver(I) induces a short term protective response. Biometals 25(3):611-616
39. Sondi I, Salopek-Sondi B (2004) Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for gramnegative bacteria. J Colloid Interface Sci 275(1):177-182 (Pubitemid 38670216)
40. Stancik LM et al (2002) pH-dependent expression of periplasmic proteins and amino acid catabolism in Escherichia coli. J Bacteriol 184(15):4246-4258 (Pubitemid 34774306)
41. Zhou Y et al (2013) Highly stable and dispersive silver nanoparticle-graphene composites by a simple and low-energy-consuming approach and their antimicrobial activity. Small 9(20):3445-3454